Evelo Biosciences, Inc.

EVLO · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$47,940$68,441$68,857$77,833
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,633$2,585$2,123$0
Total Curr. Assets$51,573$71,026$70,980$77,833
Property Plant & Equip (Net)$11,710$15,532$18,235$8,341
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,158$1,313$3,547$4,746
Total NC Assets$12,868$16,845$21,782$13,087
Other Assets$0$0$0$0
Total Assets$64,441$87,871$90,639$90,920
Liabilities
Payables$1,764$1,601$1,442$620
Short-Term Debt$2,259$1,951$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$13,068$0$0
Other Curr. Liab.$8,372$742$18,391$9,123
Total Curr. Liab.$12,395$17,362$19,833$9,743
LT Debt$48,879$54,342$40,037$19,634
Deferred Rev, NC$7,500$7,500$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$659$0$284$1,346
Total NC Liab.$57,038$61,842$40,321$20,980
Other Liabilities$0$0$0$0
Cap. Leases$7,524$7,785$9,989$0
Total Liabilities$69,433$79,204$60,154$30,723
Equity
Pref Stock$0$0$0$90,920
Common Stock$111$54$47$32
Retained Earnings-$529,222-$414,695-$292,519-$198,853
AOCI$0$0$0-$90,920
Other Equity$524,119$423,308$322,957$259,018
Total Equity-$4,992$8,667$30,485$60,197
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$64,441$87,871$90,639$90,920
Net Debt$3,198-$12,148-$28,820-$58,199